Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

IVC to merge with Evidensia
The chief executive of IVC, David Hillier, will become CEO of the combined group.
Combined group will have 500 clinics in eight countries

Corporate veterinary groups Independent Vet Care and Evidensia have announced their intention to combine their businesses, a move that will make them the largest veterinary group in Europe.

Independent Vet Care, which was founded in 2011, has over 315 clinics in the UK and employs around 800 veterinary surgeons. The group was acquired by EQT in December 2016.

Meanwhile, Evidensia has more than 180 clinics and hospitals across the Nordic region and central Europe. The business was established in 2012 as part of a merger between a number of veterinary clinics and hospitals in Sweden. Since then it has grown rapidly and now employs 1200 veterinary surgeons. It was acquired by EQT in October 2014.  

Together, IVC and Evidensia comprise around 500 clinics across eight countries.

The chief executive of IVC, David Hillier, will become CEO of the combined group.

Commenting on the merger, he said: “Our aim is to build the strongest and most respected veterinary group in Europe, founded on principles which are common to all of our practices: A passion for clinical care, a belief in teamwork, respect for the individual and entrepreneurship.

“The strong geographical presence of Evidensia in Northern Europe and of IVC in the United Kingdom is likewise complementary and will enable us to develop a dynamic network of leading clinical facilities which will benefit from our shared best practice and our improved purchasing power.”

Evidensia’s CEO, Martin Tiveus, added: “Having taken an active part in the IVC acquisition process, I am truly impressed with what David and his team has achieved so far.

“A merger between Evidensia and IVC will create the largest veterinary group in Europe and will benefit both pet owners, patients and our employees across Europe. I am proud of the team I have put together at Evidensia and I wish David and his new combined team all the best in shaping the future of veterinary care.”

Become a member or log in to add this story to your CPD history

Equine Disease Surveillance report released for Q4 2025

News Story 1
 The latest Equine Disease Surveillance report has been released, with details on equine disease from Q4 of 2025.

The report, produced by Equine Infectious Disease Surveillance, includes advice on rule changes for equine influenza vaccination.

Statistics and maps detail recent outbreaks of equine herpes virus, equine influenza, equine strangles and equine grass sickness. A series of laboratory reports provides data on virology, bacteriology, parasitology and toxicosis.

This issue also features a case study of orthoflavivus-associated neurological disease in a horse in the UK. 

Click here for more...
News Shorts
Applications open for BEVA Back in the Saddle

The British Equine Veterinary Association (BEVA) has opened applications for its 'Back in the Saddle' coaching programme.

The online scheme offers structured group coaching for members wanting to reflect on their career path and regain clarity. Members may be returning to work after leave, uncertain about next steps or reassessing direction.

Attendees will benefit from impartial guidance and practical tools to support their professional development. Members are encouraged to take a 'proactive, future-focused approach' to their careers.

The sessions, taking place on Wednesdays from 7.30pm-9pm, are open to BEVA members with more than five years' experience. The first session takes place on Wednesday, 3 June 2026.

Applications will close on Wednesday, 27 May 2026.